$9.590
-0.448 (-4.67%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CAPR Prediction & Forecast by Similar Chart Analysis
Alphio's CAPR stock price prediction model matches the current Capricor Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.54 (-0.49%). The 1-week path is $9.79 (+2.07%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Capricor Therapeutics, Inc. Stock?
Capricor Therapeutics Inc is currently a hold. The stock is trading at $9.59, showing a significant recent gain of 52.46% over the last five days, but it has a concerning forward P/E ratio of 78.74, indicating high valuation expectations. Additionally, the stock faces regulatory challenges with the FDA review of its DMD treatment delayed until November 22, which adds uncertainty to its future performance. The main risk is the potential for a Complete Response Letter from the FDA, which could severely impact the stock's price.
CAPR stock price ended at $9.59 on Friday, after losing -4.67%
Capricor Therapeutics, Inc. (CAPR) last closed at $9.59, losing -4.67%. These facts feed the 1-day and 1-week CAPR price prediction above.
Analyst Consensus
Capricor Therapeutics, Inc. (CAPR): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Capricor Therapeutics, Inc. (CAPR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CAPR, ranked by similarity.
Seasonality analysis for CAPR
Historically the probability of a positive August return for CAPR is 0.00%. December offers the highest probability of a positive month at 95.35%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CAPR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $10.86 | $13.14 | $16.30 | +37.07% |
| Sep 2026 | $10.63 | $12.91 | $13.54 | +34.59% |
| Oct 2026 | $8.24 | $12.21 | $16.03 | +27.36% |
| Nov 2026 | $12.48 | $12.69 | $16.52 | +32.33% |
| Dec 2026 | $12.37 | $13.41 | $14.03 | +39.81% |
In 2026, Capricor Therapeutics, Inc. (CAPR) is projected to range from $8.24 to $16.52.
Capricor Therapeutics, Inc. 2026 monthly forecast
In Aug 2026, Capricor Therapeutics, Inc. is projected to average $13.14, with a low of $10.86 and high of $16.30.
In Sep 2026, Capricor Therapeutics, Inc. is projected to average $12.91, with a low of $10.63 and high of $13.54.
In Oct 2026, Capricor Therapeutics, Inc. is projected to average $12.21, with a low of $8.24 and high of $16.03.
In Nov 2026, Capricor Therapeutics, Inc. is projected to average $12.69, with a low of $12.48 and high of $16.52.
In Dec 2026, Capricor Therapeutics, Inc. is projected to average $13.41, with a low of $12.37 and high of $14.03.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。